Cardiac Safety of Lansoprazole and Domperidon Combination

Summary

The aim of current study is to compare safety and efficacy of lansoprazole/domperidone 30/30 mg sustained release capsules (brand name: Duolans) and lansoprazole 30 mg micropellet capsules (brand name: Lasotab) in GERD patients in terms of cardiac safety.

Timeline

Start

2018-03-01

Primary completion

2018-12-01

Completion

2019-01-01

Drugs

Indications